{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:54:12Z","timestamp":1789203252321,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12032-015-0488-z","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T17:50:42Z","timestamp":1422467442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity"],"prefix":"10.1007","volume":"32","author":[{"given":"M. G.","family":"Alexandrakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kokonozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Boula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vyzoukaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Staphylaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Androulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tsirakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sfiridaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"key":"488_CR1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s002770000236","volume":"79","author":"O Sezer","year":"2000","unstructured":"Sezer O, Niemoller K, Eucker J, Jacob C, Kaufmann O, Zavrski I, Dietel M, Possinger K. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma. Ann Hematol. 2000;79:574\u20137.","journal-title":"Ann Hematol"},{"key":"488_CR2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ejca.2005.12.025","volume":"42","author":"CS Mitsiades","year":"2006","unstructured":"Mitsiades CS, Mitsiades NS, Munshi NC, Richardson PG, Anderson KC. The role of the bone marrow microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions. Eur J Cancer. 2006;42:1564\u201373.","journal-title":"Eur J Cancer"},{"key":"488_CR3","first-page":"176","volume":"88","author":"A Vacca","year":"2003","unstructured":"Vacca A, Ria R, Ribatti D, et al. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haematologica. 2003;88:176\u201385.","journal-title":"Haematologica"},{"key":"488_CR4","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","volume":"95","author":"B Dankbar","year":"2000","unstructured":"Dankbar B, Padro T, Leo R, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood. 2000;95:2630\u20136.","journal-title":"Blood"},{"key":"488_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cytogfr.2007.04.011","volume":"18","author":"D Ribatti","year":"2007","unstructured":"Ribatti D, Vacca A, Rusnati M, Presta M. The discovery of basic fibroblastic growth factor\/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev. 2007;18:327\u201334.","journal-title":"Cytokine Growth Factor Rev"},{"key":"488_CR6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1242\/jcs.01653","volume":"118","author":"M Scharpfenecker","year":"2005","unstructured":"Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through and internal autocrine loop mechanism. J Cell Sci. 2005;118:771\u201380.","journal-title":"J Cell Sci"},{"key":"488_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3727\/096368914X678319","volume":"23","author":"YH Hsu","year":"2014","unstructured":"Hsu YH, Chang MS. The therapeutic potential of anti-interleukin-20 monoclonal antibody. Cell Transplant. 2014;23:631\u20139.","journal-title":"Cell Transplant"},{"key":"488_CR8","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.4049\/jimmunol.0803653","volume":"182","author":"WY Chen","year":"2009","unstructured":"Chen WY. Chang MS.IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke. J Immunol. 2009;182:5003\u201312.","journal-title":"J Immunol"},{"key":"488_CR9","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/01.ATV.0000232502.88144.6f","volume":"26","author":"WY Chen","year":"2006","unstructured":"Chen WY, Cheng BC, Jiang NJ, Hsieh MY, Chang MS. IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Atherioscler Thromb Vasc Biol. 2006;26:2090\u20135.","journal-title":"Atherioscler Thromb Vasc Biol"},{"key":"488_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","volume":"104","author":"H Blumberg","year":"2001","unstructured":"Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman BA, Hammond A, Haugen H, Jelinek K, Kelly JD, Madden K, Mauer MF, Parrish-Novak J, Prunkard D, Sexson S, Sprecher C, Waggie K, West J, Whitmore TE, Yao L, Kuechle MK, Dale BA, Chandrasekher YA. Interleukin 20:discovery, receptor identification, and role in epidermal function. Cell. 2001;104:9\u201319.","journal-title":"Cell."},{"key":"488_CR11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11373-006-9087-5","volume":"13","author":"CC Wei","year":"2006","unstructured":"Wei CC, Hsu YH, Li HH, Wang YC, Hsieh MY, Chen WY, Hsing CH, Chang MS. Detection of IL-20: biological functions and clinical implications. J Biomed Sci. 2006;13:601\u201312.","journal-title":"J Biomed Sci"},{"key":"488_CR12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejim.2012.01.012","volume":"23","author":"G Tsirakis","year":"2012","unstructured":"Tsirakis G, Pappa CA, Spanoudakis M, Chochlakis D, Alegakis A, Psarakis FE, Stratinaki M, Stathopoulos EN, Alexandrakis MG. Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma. Eur J Int Med. 2012;23:368\u201373.","journal-title":"Eur J Int Med"},{"key":"488_CR13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.ejca.2011.04.012","volume":"47","author":"AM Baird","year":"2011","unstructured":"Baird AM, Gray SG, O\u2019Byrne KJ. IL-20\u00a0is epigenetically regulated in NSCLC and down regulates the expression of VEGF. Eur J Cancer. 2011;47:1908\u201318.","journal-title":"Eur J Cancer"},{"issue":"333","key":"488_CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bbrc.2005.05.122","volume":"29","author":"N Heuz\u00e9-Vourc\u2019h","year":"2005","unstructured":"Heuz\u00e9-Vourc\u2019h N, Liu M, Dalwadi H, Baratelli FE, Zhu L, Goodglick L, P\u00f5ld M, Sharma S, Ramirez RD, Shay JW, Minna JD, Strieter RM, Dubinett SM. IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression. Biochem Biophys Res Commun. 2005;29(333):470\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"488_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.gene.6364291","volume":"7","author":"MY Hsieh","year":"2006","unstructured":"Hsieh MY, Chen WY, Jiang MJ, Cheng BC, Huang TY, Chang MS. Interleukin-20 promotes angiogenesis\u00a0in a direct and indirect manner. Genes Immun. 2006;7:234\u201342.","journal-title":"Genes Immun"},{"key":"488_CR16","doi-asserted-by":"crossref","first-page":"15364","DOI":"10.1073\/pnas.0707302104","volume":"104","author":"K Tritsaris","year":"2007","unstructured":"Tritsaris K, Myren M, Ditlev SB, H\u00fcbschmann MV, van der Blom I, Hansen AJ, Olsen UB, Cao R, Zhang J, Jia T, Wahlberg E, Dissing S, Cao Y. IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc Natl Acad Sci USA. 2007;104:15364\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"488_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/mic.10.3-4.371.379","volume":"10","author":"I Buschmann","year":"2003","unstructured":"Buschmann I, Heil M, Jost M, Schaper W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation. 2003;10:371\u20139.","journal-title":"Microcirculation"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0488-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-015-0488-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0488-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T12:06:37Z","timestamp":1598702797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-015-0488-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1007\/s12032-015-0488-z","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,29]]},"article-number":"42"}}